Annual Cash & Cash Equivalents
$25.56 M
-$9.54 M-27.17%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual cash & cash equivalents is $25.56 million, with the most recent change of -$9.54 million (-27.17%) on December 31, 2023.
- During the last 3 years, FULC annual cash & cash equivalents has fallen by -$31.49 million (-55.19%).
- FULC annual cash & cash equivalents is now -73.57% below its all-time high of $96.71 million, reached on December 31, 2019.
Performance
FULC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$72.63 M
-$14.07 M-16.23%
September 30, 2024
Summary
- As of February 12, 2025, FULC quarterly cash and cash equivalents is $72.63 million, with the most recent change of -$14.07 million (-16.23%) on September 30, 2024.
- Over the past year, FULC quarterly cash and cash equivalents has increased by +$47.07 million (+184.12%).
- FULC quarterly cash and cash equivalents is now -28.51% below its all-time high of $101.60 million, reached on September 30, 2019.
Performance
FULC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FULC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.2% | +184.1% |
| 3 y3 years | -55.2% | +184.1% |
| 5 y5 years | -64.9% | +184.1% |
FULC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.8% | at low | -20.1% | +184.1% |
| 5 y | 5-year | -73.6% | at low | -27.9% | +186.2% |
| alltime | all time | -73.6% | +6180.8% | -28.5% | +186.2% |
Fulcrum Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $72.63 M(-16.2%) |
| Jun 2024 | - | $86.70 M(+117.0%) |
| Mar 2024 | - | $39.95 M(+56.3%) |
| Dec 2023 | $25.56 M(-27.2%) | $25.56 M(-15.0%) |
| Sep 2023 | - | $30.08 M(-11.4%) |
| Jun 2023 | - | $33.97 M(-2.2%) |
| Mar 2023 | - | $34.73 M(-1.0%) |
| Dec 2022 | $35.10 M(-0.9%) | $35.10 M(-61.4%) |
| Sep 2022 | - | $90.94 M(+126.5%) |
| Jun 2022 | - | $40.15 M(+20.5%) |
| Mar 2022 | - | $33.31 M(-5.9%) |
| Dec 2021 | $35.41 M | $35.41 M(-45.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $65.47 M(+15.3%) |
| Jun 2021 | - | $56.78 M(-43.6%) |
| Mar 2021 | - | $100.75 M(+76.6%) |
| Dec 2020 | $57.05 M(-41.0%) | $57.05 M(-33.1%) |
| Sep 2020 | - | $85.22 M(+12.6%) |
| Jun 2020 | - | $75.72 M(+198.3%) |
| Mar 2020 | - | $25.38 M(-73.8%) |
| Dec 2019 | $96.71 M(+32.9%) | $96.71 M(-4.8%) |
| Sep 2019 | - | $101.60 M(+104.7%) |
| Jun 2019 | - | $49.63 M(-20.5%) |
| Mar 2019 | - | $62.45 M(-14.2%) |
| Dec 2018 | $72.80 M(>+9900.0%) | $72.80 M |
| Dec 2017 | $407.00 K | - |
FAQ
- What is Fulcrum Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual cash & cash equivalents year-on-year change?
- What is Fulcrum Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Fulcrum Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FULC is $25.56 M
What is the all time high annual cash & cash equivalents for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual cash & cash equivalents is $96.71 M
What is Fulcrum Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FULC annual cash & cash equivalents has changed by -$9.54 M (-27.17%)
What is Fulcrum Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FULC is $72.63 M
What is the all time high quarterly cash and cash equivalents for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly cash and cash equivalents is $101.60 M
What is Fulcrum Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FULC quarterly cash and cash equivalents has changed by +$47.07 M (+184.12%)